Managing Adverse Effects of Obesity Medications

New medications for obesity, such as semaglutide and tirzepatide, are highly effective but can be associated with adverse effects that reduce adherence. Obesity expert and author Robert Kushner, MD, joins JAMA Deputy Editor Mary McDermott, MD, to discuss a recent JAMA Insights article on managing adverse effects of obesity medications. Related Content: Managing Adverse Effects of Incretin-Based Medications for Obesity ----------------------------------- JAMA Editors' Summary

Episode metadata supplied by the publisher feed · Published Jul 29, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Managing Adverse Effects of Obesity Medications

0:00 12:21

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of JAMA Clinical Reviews?

This episode is 12 minutes long.

When was this JAMA Clinical Reviews episode published?

This episode was published on July 29, 2025.

Can I download this JAMA Clinical Reviews episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!